Diagnosing kidney disease in the genetic era

Curr Opin Nephrol Hypertens. 2015 Jul;24(4):380-7. doi: 10.1097/MNH.0000000000000139.

Abstract

Purpose of review: Recent technological improvements have increased the use of genetic testing in the clinic. This review serves to summarize the many practical benefits of genetic testing, discusses various methodologies that can be used clinically, and exemplifies ways in which genetics is propelling the field forward in nephrology.

Recent findings: The advent of next-generation sequencing and microarray technologies has heralded an unprecedented number of discoveries in the field of nephrology, providing many opportunities for incorporating genomic diagnostics into clinical care. The use of genetic testing, particularly in pediatrics, can provide accurate diagnoses in puzzling cases, resolve misclassification of disease, and identify subsets of individuals with treatable conditions.

Summary: Genetic testing may have broad benefits for patients and their families. Knowing the precise molecular etiology of disease can help clinicians determine the exact therapeutic course, and counsel patients and their families about prognosis. Genetic discoveries can also improve the classification of kidney disease and identify new targets for therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Genetic Testing / methods
  • Genetic Therapy*
  • Genomics*
  • Humans
  • Kidney Diseases / diagnosis*
  • Kidney Diseases / genetics
  • Kidney Diseases / therapy*
  • Pathology, Molecular*
  • Prognosis